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Abstract Transient kinetics of the equine infectious anemia
virus deoxyuridine 5P-triphosphate nucleotide hydrolase were
characterized by monitoring the fluorescence of the protein. Rate
constants for the association and dissociation of substrate and
inhibitors were determined and found to be consistent with a one-
step mechanism for substrate binding. A C-terminal part of the
enzyme presumed to be flexible was removed by limited
trypsinolysis. As a result, the activity of the dUTPase was
completely quenched, but the rate constants and fluorescent
signal of the truncated enzyme were affected only to a minor
degree. We conclude that the flexible C-terminus is not a
prerequisite for substrate binding, but indispensable for catalysis.
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1. Introduction
Deoxyuridine 5P-triphosphate nucleotide hydrolase (dUTP-
ase, EC 3.6.1.23) is an enzyme in the pyrimidine-nucleotide
metabolism. It catalyzes the hydrolysis of dUTP to dUMP
and PPi, a reaction crucial for the prevention of uracil incor-
poration into DNA. In addition to being essential for the
viability of prokaryotic and eukaryotic species [1,2], its func-
tion is important for several viruses that have been found to
encode dUTPases of their own [3^5]. Enzymes in the DNA
metabolism have been used as targets for drugs against cancer
and virus-in£icted diseases. Recent investigations have shown
that dUTPase might be included among these targets [6^8].
Characterization of the enzyme, structurally and kinetically,
would be a prerequisite for the design of such drugs.
With the exception of dUTPase from the vertebrate herpes
viruses [9,10] and possibly from protozoa [11], dUTPase is a
homotrimer with a molecular mass of around 50 kDa [12^14].
It has a low KM (around 1 WM) and is highly speci¢c for
dUTP, discriminating against other pyrimidine nucleotides
mainly by di¡erences in binding strength [15^18]. The molec-
ular background for the speci¢city has been investigated by
X-ray crystallography [19,20] : the pyrimidine moiety of the
substrate is bound in a hydrophobic cleft with considerably
higher a⁄nity for uracil than for other nucleotide bases. In
the crystal structure of equine infectious anemia virus (EIAV)
dUTPase in complex with a substrate analogue, a small con-
formational shift was seen in the cleft compared to the struc-
ture of the unliganded dUTPase [19]. In these structures, and
in structures of dUTPase from other sources, a C-terminal
portion that comprises about 10% of the polypeptide is dis-
ordered and has been considered to be £exible [13,19]. It con-
tains several evolutionarily conserved residues, and has been
ascribed a functional role [21,30].
Kinetic properties of dUTPase have previously been inves-
tigated by following the formation of product [15^18]. Here,
we describe an approach not employed earlier to monitor the
enzymic reaction, namely utilizing a shift in the £uorescence
of the EIAV enzyme upon substrate binding. Using the
stopped-£ow technique, we have been able to study the tran-
sient kinetics of dUTPase ligand binding.
2. Materials and methods
2.1. Chemicals and enzymes
Chemicals were of analytical quality (Merck, Sigma, and Pharma-
cia). Nucleotides were puri¢ed before use [17,18]. Recombinant EIAV
dUTPase was produced and puri¢ed as before [12] and stored at
320‡C or in liquid N2. C-terminal truncation (cf. [22]) of the EIAV
dUTPase was carried out at 4‡C, pH 6.9 (20 mM MES), 0.4 M NaCl
and 0.1 M MgCl2 using 42 WM dUTPase and 0.4 WM bovine pancre-
atic trypsin (Sigma), followed by analysis by SDS^PAGE (High Den-
sity PhastGel, Pharmacia). The truncated enzyme was puri¢ed on a
mono-Q anion-exchange column (HR 5/5, Pharmacia) using a Bis-
Tris-bu¡ered gradient from pH 6.6, 30 mM NaCl, to pH 7.2, 0.5 M
NaCl. Chromatographic peak fractions were analyzed by matrix-as-
sisted laser desorption/ionization mass spectroscopy (MALDI^MS)
(Ludwig Institute, Uppsala, Sweden) using non-modi¢ed enzyme as
standard. Protein concentration was determined spectroscopically at
280 nm using a molar extinction coe⁄cient of 15 300 M31 cm31 [12].
2.2. Assay of dUTPase activity
The residual activity of C-terminally truncated EIAV dUTPase was
assayed using [3H]dUTP (Amersham) [23], as described by Bergman
et al. [12]. The solution of truncated enzyme was used undiluted (12
WM), while the reference, unmodi¢ed enzyme was used very diluted
(0.23 nM). Samples identical to those above, but with 0.01% sodium
azide added, were run in parallel. The samples were incubated at
room temperature for 24, 36 and 48 h. After subtraction of back-
grounds, the ratio of dUMP over total nucleotide minus blank activity
was plotted against incubation time. Samples containing sodium azide
showed similar (with non-modi¢ed enzyme, even slightly lower) activ-
ity compared to those without, indicating that there were no artefacts
in the results originating from contamination of biological activity,
considering the long incubation time at room temperature.
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2.3. Fluorescence measurements
Emission and excitation spectra were obtained with a Perkin-Elmer
LS 50B spectrometer using 0.1^1 WM dUTPase. Time-resolved £uo-
rescence measurements were carried out using an Applied Photophy-
sics SX17.MV stopped-£ow spectrophotometer with a dead time of
1.3 ms [24], 280 nm excitation wavelength, and a ¢lter with a cut-o¡ at
325 nm, allowing transmission of emitted light of longer wavelengths.
With a maximum resolution of 80 data points per ms, 4000 data
points were recorded for each reaction, using split timebase in the
experiments where dUTP was expected to be hydrolyzed. One data
set is the average of about 5^15 reaction traces.
The total enzyme concentration used was 1^2.5 WM. The concen-
tration of active dUTPase during stopped-£ow experiments was 0.3^1
WM, depending on the experiment, as calculated using kcat for dUTP
[18] and a Vmax estimated from progression curves obtained at high
Cs, both by dividing the integrated area over the curve with the
maximum signal amplitude, and by estimating the time of the in£ex-
ion point of the substrate depletion phase. The two approaches gave
equal results.
2.4. Evaluation of stopped-£ow data
A mono-exponential equation was ¢tted to the progression curves,
using the SX17.MV or SX18.MV software and data points from the
dead time to seven half-times or longer. In the case of curves of dUTP
hydrolysis, the starting value of the ¢tted function was ¢xed, assumed
to equal the ¢nal £uorescence level. The observed rate constant thus
obtained, kobs, was plotted versus ligand concentration. The apparent
rate constants, kind and kdep (see Section 3.1), were obtained from the
intercept and the slope of the plot, respectively, by linear regression
(Microcal Origin v4.1) that takes the standard deviation in the kobs
values into account. The plots were linear (see Figs. 2 and 3), but to
ensure that the relatively high enzyme concentration used did not
a¡ect the estimates of kdep and kind, the data were also subjected to
numerical integration using the software DYNAFIT [25] assuming the
model E+S1ES, and using various values for enzyme concentration.
3. Results
3.1. Quenching of £uorescence upon ligand binding
On excitation with light of 280 nm wavelength, the EIAV
dUTPase gives a £uorescence spectrum with a maximum
around 340 nm (not shown), indicating a tryptophan residue
as the source. Upon ligand binding (e.g. dUTP), emission
above 325 nm decreases in intensity. This was exploited using
a stopped-£ow spectrophotometer for rapid mixing of enzyme
and ligand solutions in order to monitor the formation of the
enzyme^ligand complex (EL). With dUTP as the ligand, the
¢rst phase, the build-up of the EL concentration (Fig. 1a), is
followed by the steady-state phase of substrate hydrolysis and
ultimately, as the substrate is consumed, by a return to the
intensity of the free enzyme (Fig. 1, inset).
By ¢tting a mono-exponential equation to the pre-steady-
state phase, a rate constant, kobs, was obtained, which de-
scribes the rate of relaxation towards steady state or equilib-
rium. kobs displays a linear dependence on ligand concentra-
tion for all ligand species investigated (Figs. 2 and 3). The
relation can be described by Eq. 1, where the subscripts
‘dep’ and ‘ind’ denote dependence and independence, respec-
tively, of ligand concentration.
kobs  kdepCL  kind 1
If the event giving rise to the £uorescence signal was separate
from the step of encounter of enzyme and ligand, kobs should
£atten out at the higher ligand concentrations used here. In
attempts at a hyperbolic treatment of the experimental data,
such a saturation could not be seen. Thus, any event between
encounter and £uorescence shift is too fast to be relevant to
the interpretations here. This conclusion is supported by the
fact that kdep for various ligands (see Sections 3.2 and 3.3) is
in the same range as the association rate constants for other
nucleotide binding enzymes (see Hiromi [26] for a compila-
tion). Thus, a scheme representing the reaction can be written
as:
E  Sk1
k31
ESÿ!kcat E  P 2
Fig. 1. Quenching of the £uorescence of dUTPase after mixing with
dUTP in the stopped-£ow cuvette. Inset: Fast formation of the EL,
and return to the starting level after consumption of the substrate.
a: Close-up of the ligand binding to functional dUTPase. b: Trun-
cated dUTPase (Section 2.1). Fitting of a mono-exponential func-
tion to the data (e.g. curve a) results in an observed rate constant,
kobs, which is shown plotted against ligand concentration in Figs. 2
and 3.
Fig. 2. Analysis of rate constants for the natural substrate dUTP:
kobs, obtained as in Fig. 1, as a function of dUTP concentration
and pH (dashed lines). Also included: kobs for dUTP at pH 8.0
with dUTPase truncated by the removal of 16 residues from the C-
terminus (see Section 2.1) (solid line).
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The slope of a plot of Eq. 1, kdep, is taken to represent the
second-order rate constant, k1, while the intercept, kind, would
be constituted by k31+kcat, the rate constants independent of
ligand concentration:
kobs  k1 CL  k31  kcat 3
Fast rearrangement steps between the ¢rst and second steps in
Eq. 2 cannot be excluded. In the measurements with the non-
hydrolyzable nucleotides dUDP and 2P-deoxyuridine 5P-(K,L-
imido)triphosphate (dUPNPP) [27], and in the case where the
catalytic activity of the enzyme had been abolished by trun-
cation (see Section 3.4), step 2 in Eq. 2 vanishes, kcat in Eq. 3
becomes zero, and kind equals k31.
3.2. dUTPase and dUTP
For dUTP at pH 8.0, kdep was determined to be 106 þ 9
WM31 s31 and kind 95 þ 26 s31. The ratio of kind to kdep is
in agreement with the KM value (Table 1) determined earlier
by monitoring the protons formed in the hydrolysis of dUTP
[18]. The signal amplitude from steady state to completion of
the reaction displays a hyperbolic dependence on dUTP con-
centration with a value of the half-saturation constant similar
to the KM value (not shown). To use the model above, k1
takes the value of kdep, while kcat, determined earlier to be
25 s31 [18], can be used to calculate k31. Subtraction from
kind gives a value of 70 þ 27 s31 for k31.
The rate constants for dUTP are pH-dependent (Fig. 2,
Table 1), showing a lower kdep and kind at pH 9.5 and higher
values at lower pH (pH 7.0 and 6.3): at pH 6.3, the rate was
too fast to be accurately determined, and consequently a pKa
could not be estimated. The ratio of kind to kdep, however,
does not change signi¢cantly with pH, except at pH 9.5, where
the value is somewhat higher. That the ratio has the same
value at pH 7 and pH 8 is consistent with determinations of
KM at steady state [17,18]. These studies also corroborate the
increase at higher pH, and have attributed it to titration of the
uracil moiety of the substrate. The pH dependence of the rate
constants around neutral pH is, however, an unexpected nov-
elty, and points to features of the active site of dUTPase that
are yet unknown.
3.3. Ligands other than the substrate
We then tested several inhibitory ligands of which dUMP
and dTTP were found to reach equilibrium or steady state too
fast to be measured. dUDP and dUPNPP showed rate con-
stants in the same order of magnitude as the values found for
dUTP (Table 1, Fig. 3). In both cases (Table 1), the ratio of
kind to kdep is similar to the Ki previously determined [18],
supporting the validity of the approach presented here.
dUDP gives a signal amplitude of the same magnitude as
dUPNPP and dUTP.
3.4. Properties of truncated EIAV dUTPase
In the X-ray structures of homotrimeric dUTPases available
in the data banks [13,19,28]1, the around 16 residues long C-
terminus is unde¢ned, which would suggest that it is £exible.
However, this stretch is important for activity [21,22] although
the role it plays in the reaction has not been clari¢ed.
We removed the £exible C-terminal arm of the EIAV
dUTPase by limited trypsinolysis, following in essence the
procedure described for the E. coli dUTPase by Vertessy
[22]. After puri¢cation, the truncated protein has a well-de-
¢ned molecular mass of 13 230 kDa (SDS^PAGE and MAL-
DI^MS, not shown) indicating Lys119 to be the last residue.
Upon removal of the C-terminal peptide, activity decreases
by a factor of about 105 according to the assay based on
hydrolysis of [3H]dUTP (see Section 2.2). The residual activity
might originate from incompletely digested enzyme co-puri-
¢ed with the truncated form. Alternatively, dUTPase, devoid
of its C-terminal arm, may indeed possess an intrinsic but
minuscule hydrolytic activity. In contrast, for truncated E.
coli dUTPase, Vertessy [22] reported a signi¢cant residual
activity. The di¡erence between the two truncated proteins
is notable, since the kinetic properties of the intact enzymes
are comparable [17,18].
Fluorescence stopped-£ow measurements con¢rm that the
truncated EIAV dUTPase lacks activity. However, the protein
binds the ligands dUTP and dUPNPP (solid lines in Figs. 2
and 3) with kind and kdep values (Table 1) similar to the ones
obtained with the intact enzyme. The signal amplitudes (Fig.
1b) were also the same as obtained with the native enzyme,
implying that the £exible arm does not cause the £uorescence
shift. This is further supported by the fact that dUDP, which
does not interact with the C-terminal arm [19,30], gives as
high a signal with the native enzyme as the other nucleotides.
4. Discussion
In the present study, we found that binding of deoxyuridine
nucleotides to the EIAV dUTPase causes a shift in £uores-
cence, which in the case of dUTP, the substrate of the enzyme,
becomes reversed upon hydrolysis of the nucleotide. The ob-
served shift could re£ect a change in the enzyme structure
intimately connected with the catalysis. This change may be
Fig. 3. Analysis of rate constants for non-hydrolyzable substrate
analogues: kobs, obtained at pH 8.0 using di¡erent concentrations
of dUDP and dUPNPP [27] with native dUTPase (dashed lines),
and of dUPNPP with truncated (Section 2.1) enzyme (solid line).
1 EIAV, Escherichia coli, and feline immunode¢ciency virus. The co-
ordinates for the human dUTPase by Mol et al. [29] have not yet been
deposited. Consequently, their ¢nding that the C-terminal is ordered
in complex with deoxyuridine nucleotide cannot be dealt with here.
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related to that observed by X-ray di¡raction upon binding of
dUDP [19]. Intact enzyme and enzyme with the £exible C-
terminal arm removed behave similarly with respect to £uo-
rescence implying that the structural change is con¢ned to the
globular part of the enzyme not involving the arm. The source
of the £uorescence signal may be the tryptophan residues
(Trp52), one from each of the subunits in the trimer, located
at the three-fold axis of the enzyme. According to the crystal
structures (Dauter, personal communication, 1999) [19], the
orientation of the tryptophan side chains changes slightly
upon nucleotide binding. X-ray di¡raction to atomic resolu-
tion could be useful for a closer analysis of the events taking
place upon nucleotide binding and in attempts at an unequiv-
ocal assignment of the £uorophore. However, identi¢cation of
the £uorophore is not a prerequisite for further analysis and
interpretation of the rate constants obtained here.
The results of the present work are consistent with an ear-
lier report of kinetic parameters (kcat, KM, Ki) for the EIAV
dUTPase that were acquired by monitoring protons released
in the substrate hydrolysis [18]. In addition, our data contrib-
ute to a more detailed picture of the dUTPase reaction. The
rate constants obtained are the ¢rst ones describing events in
the dUTPase reaction ahead of its rate-limiting step. As seen
in Section 3.1, the rates observed at di¡erent ligand concen-
trations can be interpreted straightforwardly by use of a one-
step binding model. The scheme for substrate binding and
hydrolysis (Eq. 2) and its cognate rate equation (Eq. 3) are
supported by the data and state that the constants kdep and
kind determined here (Table 1) are k1 and the sum of k31 and
kcat, respectively. By subtracting kcat for dUTP [18] from kind,
a value for k31 is obtained (Section 2). The di¡erence between
k31 and kcat at pH 8 is consistent with approximately every
fourth substrate molecule bound to the enzyme becoming hy-
drolyzed, which corroborates the notion of dUTPase as an
e⁄cient enzyme (cf. Larsson et al. [17]). Furthermore, the
assessment of the constants k1 and k31 provides, for the ¢rst
time, access to a dissociation constant for Mg-dUTP from a
dUTPase^substrate complex (Ks). A value for Ks allows an
estimate of the di¡erence in binding strength of dUTP and
dUDP, a substrate analogue often used in X-ray studies of
dUTPase. Our data indicate that Ks for dUTP is merely some
¢ve times lower than the Ki for dUDP [18]. Thus, introduc-
tion of the Q-phosphate does not provide a substantial increase
in binding strength. This ¢nding is notable since, in the X-ray
structure [19], a cluster of lysine residues is present in the
region of the active site, where the Q-phosphate is thought
to bind, and, conceivably, capable of contributing to binding.
The fact that the rate constants for native and C-terminally
truncated enzyme show no major di¡erences strongly argues
that the arm is not required in the substrate binding step. A
competition between the arm and the ligand entering the ac-
tive site (which would be expected, were there a high occu-
pancy of the arm over the active site) would have made k1
increase when the arm is removed. Instead, truncation causes
a small decrease in k1 and a slight increase in k31 for dUTP
and dUPNPP. These changes in the values might be attributed
to a reduced electrostatic attraction between the negatively
charged substrate and the enzyme due to removal of the pos-
itively charged C-terminus (cf. Adolph et al. [24]). The view
that electrostatic interactions are involved gets support from a
comparison between k1 for dUDP and for the substrate. The
ligand with less charge has the lower k1. In conclusion, with-
out a signi¢cant change in either the rate constants or the
thermodynamic dissociation constant (k31 over k1) upon trun-
cation, the C-terminal arm cannot play a role in the substrate
binding step of dUTPase.
In the literature, the arm has often been ascribed an ad-
vanced role in the dUTPase reaction [29,30]. It has been sug-
gested that the binding of substrate would induce a conforma-
tional change, resulting in the arm forming a lid on top of the
substrate that after hydrolytic cleavage of the substrate opens
up to release the products [30], facilitating the product release
by pulling the newly formed dUMP out of the active site [29].
Our data may support a di¡erent view. Removal of the arm
a¡ects the rates and strength of ligand binding only to a
minor degree. Since the arm is essential for catalysis, its
main function could be to bring residues with catalytic roles
to the bound substrate and to participate in hydrolysis (step 2
in Eq. 2). Clearly, there is a need for further investigation of
the structural and dynamic properties of the arm.
The activity of the truncated enzyme is reduced to a level
close to zero. A complex of truncated enzyme and the natural
substrate might therefore be able to be analyzed by X-ray
studies. Since removal of the arm does not largely a¡ect the
thermodynamic dissociation constant, it is likely that such an
approach would reveal structural features of the catalytic
complex.
The method of £uorescence-monitored transient kinetics
Table 1
Pre-steady-state rate constants of ligand binding to EIAV dUTPase
Complex kdep (WM31 s31) kind (s31) Calculated kind/kdep (WM) Steady-state KM (WM)e
Functional dUTPase with
dUTPa pH 7.0 142 þ 9.4 183 þ 25 1.29 þ 0.20 1.1 þ 0.1
pH 8.0 106 þ 9 95 þ 26 0.90 þ 0.25 1.1 þ 0.1
pH 9.5 51 þ 1.3 95 þ 5.6 1.86 þ 0.12 ^
dUPNPPb;c pH 8.0 72 þ 7 15 þ 11 0.21 þ 0.16 0.6 þ 0.03
dUDPb pH 8.0 40 þ 9 265 þ 39 6.6 þ 1.8 3.6 þ 0.1
Truncated dUTPased with
dUTPa pH 8.0 79 þ 6 114 þ 19 1.4 þ 0.27 ^
dUPNPPb;c pH 8.0 47 þ 1 23 þ 3 0.49 þ 0.06 ^
The constants kdep and kind obtained for the £uorescence shift are shown to equal k1 and k31+kcat, respectively, in Eq. 2 (kind equals k31,
when no product formation occurs, see footnotes b and d).
aSubstrate.
bNon-hydrolyzable substrate analogue.
cPersson et al. [27].
dEIAV dUTPase deprived of its C-terminal 16-residue peptide, see Section 2.1.
eKM and Ki determined at steady state by monitoring proton release from the hydrolysis [18].
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applied on dUTPase, as described here, could have wider
applications. The method detects binding independently of
catalytic activity. Just like the truncated inactive variant of
EIAV dUTPase investigated in the present study, genetically
engineered variants of the enzyme could be characterized us-
ing the method described here, and the in£uence of individual
amino acid side chains on substrate binding be analyzed.
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